Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome; Myalgic Encephalomyelitis Interventions: Drug: NAC 900mg/day; Drug: NAC 3600mg/day; Drug: NAC 0mg/day (Placebo) Sponsors: Weill Medical College of Cornell University; National Institute of Neurological Disorders and Stroke (NINDS) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials